KRM Ayurveda

Why is KRM Ayurveda Ltd falling/rising?

As of 19-Jun, KRM Ayurveda Ltd's stock price is at 236.90, down 3.03%, underperforming against the Sensex, which has risen by 1.65%. Despite the price decline, investor interest has increased significantly, though the stock remains below its moving averages, indicating short-term weakness.

As of 19-Jun, KRM Ayurveda Ltd's stock price is falling, currently at 236.90, which reflects a decrease of 7.4 or 3.03%. The stock has underperformed compared to the benchmark Sensex, which has increased by 1.65% over the past week, while KRM Ayurveda Ltd has declined by 2.77%. Additionally, the stock's performance over the past month shows a decrease of 1.93%, contrasting with the Sensex's gain of 1.67%. <BR><BR>Despite the current price drop, there has been a notable increase in investor participation, with a delivery volume of 37,000 shares on June 18, which is up by 74.53% compared to the 5-day average. This suggests that while the stock is experiencing a decline in price, there is growing interest among investors. However, the stock is currently trading below its 5-day and 20-day moving averages, indicating short-term weakness. Overall, the combination of underperformance relative to the market and the recent price drop contributes to the current decline in KRM Ayurveda Ltd's stock price.

Which are the latest news on KRM Ayurveda?

What does KRM Ayurveda do?

KRM Ayurveda Ltd operates hospitals and clinics in India, offering telemedicine services. It is a micro-cap company with a market cap of INR 493 Cr, and it was converted to a Public Limited Company in December 2024.

Overview:<BR>KRM Ayurveda Ltd operates a network of hospitals and clinics in India and offers telemedicine consulting and sales, positioning itself within the healthcare services industry as a micro-cap company.<BR><BR>History:<BR>KRM Ayurveda Limited was incorporated as a Private Limited Company on September 03, 2019, and later converted into a Public Limited Company on December 24, 2024. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 493 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00<BR>Industry P/E: 60<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.41<BR>Return on Equity: 17.54%<BR>Price-to-Book: 4.30<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is KRM Ayurveda?

As of 10th June, KRM Ayurveda Ltd has a market capitalization of 493.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: KRM Ayurveda Ltd has a market capitalization of 493.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 23.88 Cr and Total Assets valued at 66.79 Cr.

Who are the peers of the KRM Ayurveda?

KRM Ayurveda's peers include Tarsons Products, 3B Blackbio, Health X Platfor, Take Solutions, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv. Their management risks and growth rates vary, with Take Solutions showing the highest 1-year return at 228.18% and Tarsons Products the lowest at -44.95%.

Peers: The peers of KRM Ayurveda are Tarsons Products, 3B Blackbio, Health X Platfor, Take Solutions, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv.<BR><BR>Quality Snapshot: Excellent management risk is observed at Prevest Denpro, while Average management risk is found at 3B Blackbio, QMS Medical, and Hemant Surgical, and the rest have Below Average management risk. Growth is Excellent at One Global Serv, Good at Hemant Surgical, and Average at Health X Platfor, while the rest exhibit Below Average growth. Capital Structure is Excellent at 3B Blackbio and Prevest Denpro, Good at Tarsons Products and Nureca, Average at QMS Medical, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Take Solutions at 228.18%, while the lowest is Tarsons Products at -44.95%. KRM Ayurveda's 1-year return is not available for comparison. Additionally, Nureca, Take Solutions, and Health X Platfor have negative six-month returns.